Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) Interest Coverage Ratio (2022 - 2026)

Indivior Pharmaceuticals has reported Interest Coverage Ratio over the past 5 years, most recently at 19.57 for Q1 2026.

  • For Q1 2026, Interest Coverage Ratio rose 255.84% year-over-year to 19.57; the TTM value through Mar 2026 reached 8.32, up 416.72%, while the annual FY2025 figure was 5.82, 1137.87% up from the prior year.
  • Interest Coverage Ratio for Q1 2026 was 19.57 at Indivior Pharmaceuticals, up from 13.5 in the prior quarter.
  • Over five years, Interest Coverage Ratio peaked at 32.25 in Q4 2022 and troughed at 13.11 in Q2 2024.
  • A 5-year average of 3.57 and a median of 3.38 in 2025 define the central range for Interest Coverage Ratio.
  • Biggest five-year swings in Interest Coverage Ratio: plummeted 120.67% in 2023 and later skyrocketed 510.87% in 2025.
  • Year by year, Interest Coverage Ratio stood at 32.25 in 2022, then crashed by 120.67% to 6.67 in 2023, then skyrocketed by 50.71% to 3.29 in 2024, then skyrocketed by 510.87% to 13.5 in 2025, then skyrocketed by 44.97% to 19.57 in 2026.
  • Business Quant data shows Interest Coverage Ratio for INDV at 19.57 in Q1 2026, 13.5 in Q4 2025, and 3.58 in Q3 2025.